resmed inc (RMD:New York)
resmed inc (RMD) Snapshot
|
Open
$50.10
|
Previous Close
$50.08
|
|
|
Day High
$50.81
|
Day Low
$49.56
|
|
|
52 Week High
05/14/13 - $51.40
|
52 Week Low
06/28/12 - $29.82
|
|
|
Market Cap
7.1B
|
Average Volume 10 Days
846.2K
|
|
|
EPS TTM
$2.13
|
Shares Outstanding
142.5M
|
|
|
EX-Date
05/17/13
|
P/E TM
23.3x
|
|
|
Dividend
$0.68
|
Dividend Yield
1.37%
|
Related News
resmed inc (RMD) Related Businessweek News
No Related Businessweek News Foundresmed inc (RMD) Details
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers various products for the treatment of obstructive sleep apnea and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear products, and ventilation devices, as well as other optional accessories, such as cold passover humidifiers, carry bags, and breathing circuits. The company also provides data communications and data control products consisting of EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors, independent manufacturers, representatives, and direct sales force in approximately 70 countries primarily in the United States, Germany, France, the United Kingdom, Switzerland, Australia, Japan, Norway, and Sweden. ResMed Inc. was founded in 1989 and is based in San Diego, California.
resmed inc (RMD) Top Compensated Officers
resmed inc (RMD) Key Developments
ResMed Inc. Presents at UBS Global Healthcare Conference, May-21-2013 02:00 PM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: David Pendarvis, Chief Administrative Officer, Global General Counsel and Secretary.
ResMed Inc. announced unaudited consolidated cash flow results for the nine months March 31, 2013. For the period, the company reported net cash provided by operating activities was $278,901,000 against $286,182,000 a year ago. Purchases of property, plant and equipment was $47,576,000 against $35,067,000 a year ago.
ResMed Inc. announced the launch of a new product on April 25, 2012: VPAP COPD. The VPAP COPD is the first and only home bilevel cleared by the FDA specifically for the treatment of chronic obstructive pulmonary disease (COPD), giving patients and payors a weapon in the fight to keep COPD patients out of the hospital. It has also developed new ClimateLine TM Oxy tubing that connects between the humidifier and mask, with an oxygen line input next to the VPAP COPD device, enhancing comfort and ease of use. Both of these products will improve the lives of patients suffering from this debilitating and costly chronic disease.
| Recently Viewed | |||
| RMD:US | $49.72 USD | -0.36 | |
| Company | Last | Change |
| Edwards Lifesciences Corp | $64.30 USD | -1.70 |
| Hologic Inc | $20.46 USD | -0.81 |
| Mettler-Toledo International Inc | $220.30 USD | -3.09 |
| Cooper Cos Inc/The | $107.22 USD | -3.77 |
| Varian Medical Systems Inc | $68.43 USD | -1.45 |
| View Industry Companies | ||
Industry Analysis
RMD
Industry Average
| Valuation | RMD | Industry Range |
| Price/Earnings | 23.5x |
|
| Price/Sales | 4.9x |
|
| Price/Book | 4.0x |
|
| Price/Cash Flow | 22.1x |
|
| TEV/Sales | 3.9x |
|
Post a JobJobs
- San Diego, CA | ResMedPosted: Apr 30
- San Diego, CA | ResMedPosted: Apr 30
- San Diego, CA | ResMedPosted: May 01
- San Diego, CA | ResMedPosted: Apr 25
Sponsored Financial Commentaries
Sponsored Links
To contact RESMED INC, please visit www.resmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







